Evaluation of the Binding of Radiolabeled Rituximab to CD20-Positive Lymphoma Cells: An In Vitro Feasibility Study Concerning Low-Dose-Rate Radioimmunotherapy with the α -Emitter 227 Th
Melhus, Katrine B., Larsen, Roy H., Stokke, Trond, Kaalhus, Olav, Selbo, Pål K., Dahle, JosteinVolume:
22
Language:
english
Journal:
Cancer Biotherapy & Radiopharmaceuticals
DOI:
10.1089/cbr.2007.371
Date:
August, 2007
File:
PDF, 393 KB
english, 2007